Breaking News

Coronavirus Live Updates: Covid-19 Task Force Recommends Use Of Anti -Malarial Drug Choloroquine For Treatment

 As Coronavirus cases climbed to 418 on Monday, several states of India announced a complete lockdown till the end of the month. From Maharashtra to Uttar Pradesh and From Punjab to Kerala, different states announced a slew of measures after a surge in Coronavirus cases across the nation. On the other hand, the Centre has asked state governments to strictly enforce the lockdown and take legal action against those who violated the restrictions.

Any person disobeying any regulation or order made under this Act shall be deemed to have committed an offence punishable under section 188 of the Indian Penal Code, which can lead to a jail term of six months, a fine of Rs 1000, or both. However, during the lockdown, India Latest News state administrations have been advised to keep the essential services running. Hospitals, medical stores grocery and vegetable shops are asked to function normally.



But an important question still persists that is India’s move to lockdown much of the world’s second-most populous country enough to soften the impact of the coronavirus outbreak?

Stay tuned to ABP News to get the LIVE Updates on coronavirus and its effect in India.
By : ABP News Bureau | Updated: 23 Mar 2020 04:08 PM (IST)

4:06 PM IST | 23 MAR 2020
Chloroquine disappears from drug stores in Indore

Chloroquine, an anti-malarial drug, has now become the most sought after medicine after reports emerged that it is proving effective in the fight against coronavirus. Press Release Distribution Service It is being claimed that chloroquine has disappeared from the drug stores in Indore and some even claim that the drug is being supplied to the United States. As per the initial study, chloroquine treatment of COVID-19 patients had clinical and virologic benefit versus a comparison group. Chloroquine was added as a recommended antiviral for treatment of COVID-19, though clinical trials is still going on.

For More Information 

No comments